Lenz Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Solana Beach, CA, United States
- PrincipalsDaniel R. ChevallardChief Financial OfficerEvert B. SchimmelpenninkPresident, CEO and SecretaryMarc OdrichChief Medical Officerand 3 more
- CompanyLenz Therapeutics, Inc.Solana Beach, CA, United States
- Phone line+1 (858) 925-7000General business
LENZ Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker LENZ) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 6
Chief executive
Evert B. SchimmelpenninkPresident, CEO and Secretary
Finance
Daniel R. ChevallardChief Financial Officer
Sales & commercial
Shawn OlssonChief Commercial Officer
Everyone else on file (1)
Marc OdrichChief Medical Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Daniel R. Chevallard — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Evert B. Schimmelpennink — President, CEO and Secretary
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Marc Odrich — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Shawn Olsson — Chief Commercial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capability